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The purpose of the present study was to investigate the interaction between ketotifen fumarate and 
anhydrous theophylline in aqueous media of various pH (1.2 and 6.8). Using Job’s continuous-variation 
analysis and Ardon’s spectrophotomeric measurement methods, the values of the stability constants of 
theophylline with ketotifen were determined at a fixed temperature (37 oC) at various pH. The stability 
constants, ranging between 5.66 and 9.92, were derived from Ardon’s plot, indicating that comparatively 
stable complexes had formed as a result of an interaction between the drugs. However, following the 
interaction of theophylline with ketotifen, stability constants were <1 at gastric pH (1.2) and intestinal 
pH (6.8). Concurrent administration of ketotifen and theophylline could result in the formation of a stable 
complex and this is likely to reduce the therapeutic activities of both drugs.
Uniterms: Stability constant. Job’s method. Ardon’s method. Ketotifen. Theophylline.
O objetivo do presente estudo foi investigar a interação entre o fumarato de cetotifeno e a teofilina 
anidra em meios aquosos com vários pH (1,2 e 6,8). Utilizando a análise da variação contínua de Job 
e os métodos de medida espectrofotométrica de Ardon, os valores das constantes de estabilidade da 
teofilina com o cetotifeno foram determinados em temperatura fixa (37 oC) em vários pH. As constantes 
de estabilidade, variando entre 5,66 e 9,92 derivaram-se a partir do delineamento de Ardon, indicando, 
comparativamente, que complexos estáveis se formaram como resultado da interação entre os fármacos. 
Entretanto, seguindo a interação da teofilina com o cetotifeno, as constantes de estabilidade foram <1, 
em pH gástrico (1,2) e intestinal (8,8). A administração concomitante de cetotifeno e teofilina poderia 
resultar na formação de complexo estável, o que reduz a atividade terapêutica de ambos os fármacos. 
Uniterms: Constante de estabilidade. Método de Job. Método de Ardon. Cetotifeno. Teofilina.
INTRODUCTION
Ketotifen is a benzocycloheptathiophene derivative 
that has been shown to possess anti-histaminic and anti-
anaphylactic properties (Martin, Romer, 1978). It has been 
demonstrated that it can block the in vitro release of media-
tors from rat peritoneal mast cells (Martin, Romer, 1978). 
The drug inhibits the release of histamine and leukotrienes 
from basophils and lung tissue, antagonises histamine at 
H1 receptors, inhibits calcium uptake, blocks the passive 
cutaneous anaphylactic reaction, reverses isoprenaline-
induced beta-adrenoceptor tachyphylaxis, and inhibits 
both allergen-induced and drug-induced asthma (Craps, 
Greenwood, Radielovic, 1978). A number of clinical tri-
als of ketotifen have shown to have a beneficial effect in 
the treatment of asthma (Hoshino et al., 1998; Tinkelman 
et al., 1985) equivalent to that of disodium cromoglycate, 
which has an established place in the treatment of asthma 
(B.H./M.R.C.C.T., 1972; Clarke, May, 1980). Ketotifen, 
which is useful in the treatment of hay fever and asthma, 
has been found to inhibit anaphylactic histamine release 
from animal tissues (Martin et al., 1980). Theophylline, also 
known as dimethylxanthine, is a xanthine with bronchodi-
lator properties and is used in the treatment of asthma and 
chronic obstructive pulmonary disease (COPD). Moreover, 
theophylline has been shown to have some anti-inflamma-
tory activities, inhibiting the activity of CD4 lymphocytes 
in vitro and mediator release from mast cells (Salamzadeh 
et al., 2008). It also inhibits bronchoconstriction produced 
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by exercise and challenge testing, and has been shown to 
have beneficial effects on the contraction of the diaphragm, 
an effect which may be particularly useful in patients with 
COPD (Kidney et al., 1990; Mak, 1997). Drug-drug inter-
actions occur when one therapeutic agent either alters the 
concentration (pharmacokinetic interactions) or the bio-
logical effect (pharmacodynamic interactions) of another 
agent (Leucuta, Vlase, 2006). The clinical significance of 
a specific drug-drug interaction depends on the degree of 
accumulation of the substrate and the therapeutic window 
of the substrate (Bachmann, Lewis, 2005). The combination 
of theophylline and ketotifen is often used in respiratory 
tract infections and some have suggested that the combi-
nation is effective (Benjamin et al., 1994), while others 
have postulated that the combination may be embryotoxic, 
leading to growth retardation and morphological abnormali-
ties (Bechter, Schön, 1988). The major goal of the present 
study was to elucidate the possible importance of drug-drug 
interactions (DDIs) as a contributing factor towards drug 
safety and finally to observe and determine the stability of 
the complexes which could be formed by the interaction of 
ketotifen fumarate with anhydrous theophylline in aqueous 
media at variable pH. The values of the stability constants 
of theophylline with ketotifen were determined using Job’s 
continuous-variation analysis and Ardon’s spectropho-
tomeric measurement methods. However, following the 
interaction of theophylline with ketotifen, stability constants 
ranged between 0.4-2.0 at pH 1.2 and 4.12 at pH. 6. The sta-
bility constant values indicate that co-administration of both 
drugs may reduce the pharmacological effect of the drugs.
MATERIAL AND METHODS
Drugs and chemicals
Ketotifen fumarate and anhydrous theophylline 
were obtained from Square Pharmaceuticals Ltd., Dhaka, 
Bangladesh as a gift and were used without further purifi-
cation. Sodium dihydrogen orthophosphate and disodium 
hydrogen orthophosphate, used for the preparation of 
buffer solutions, were purchased from Merck, Germany. 
Potassium chloride, sodium hydroxide and potassium 
hydroxide were all of reagent grade.
Equipment
For these tests, we used a UV-Visible spectrometer 
(model no. UV-1600, Shimadzu, Japan), a pH meter (Met-
tler Toledo, Switzerland), an analytical balance (model 
number: AL 204-S/01) (Mettler Toledo, Switzerland), and 
a thermostatted water bath (Shimadzu, Japan). A Dunbuff 
metabolic shaking incubator (Nickel, Electrical Company, 
England) was used to shake the drug mixtures to attain 
equilibrium.
Preparation of standard solutions
Stock solutions of ketotifen fumarate (1x10-3 M) and 
anhydrous theophylline(1x10-3 M) prepared by dissolving 
them in distilled water. These stock solutions were diluted 
to the desired concentration (1x10-5 M) in the buffer solu-
tions to obtain the working standard solutions.
Absorption spectrum analysis
In the observation of the spectra, the absorption 
characteristics of ketotifen fumarate and theophylline 
and their 1:1, 1:2, and 2:1 mixtures in the buffer solutions 
(Perrin, Dempsey, 1974; Mohiuddin et al., 2009) at pH 1.2 
and 6.8 were compared with those of each interacting spe-
cies. The concentrations of the sample were kept at very 
dilute levels in each case and the measurements made 
using the UV-VIS spectrophotometer were taken at a con-
stant temperature of the cell compartment and automatic 
recording unit. The stock solutions of the samples were 
diluted to the appropriate levels with the buffers (1x10-5 M) 
at the desired pH and the spectra were recorded between 
400-190 nm. The spectra were compared with those of the 
pure samples in each case.
Job’s spectrophotometric method
According to Job’s method (Job, 1971) a series of 
solutions were prepared in which the analytical concentra-
tion of one reactant (usually the cation) was held constant 
while that of the other was varied. The absorbance of a 
series of ketotifen fumarate with theophylline in different 
molar ratios (1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 8:2, 9:1) was 
measured by keeping the total molar concentration constant. 
The observed absorbance of the mixtures at various molar 
fractions was subtracted from the sum of the values for the 
free drugs (ketotifen fumarate and anhydrous theophylline). 
The absorbance difference (D) was then plotted against the 
molar fractions of the drug in the mixtures. If the forma-
tion constant is reasonably favourable, two straight lines 
with different slopes that intersect at a molar ratio that cor-
responds to the ratio of drugs in the complex are obtained.
Ardon’s spectrometric method
The anhydrous theophylline concentration was kept 
fixed (2x10-4) while the ketotifen concentrations were 
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varied. The absorbance of free drug solutions and those of 
mixtures were measured at 300 nm at different pH. From 
Ardon’s equation (Ardon, 1971) the values of 1/(D-CɛA) 
versus 1/drug were plotted and the values of the stability 
constants were calculated from the intercept/slope of the 
straight lines. In the above equation D is the absorbance 
of the mixture, C is the molar concentration of ketotifen, 
and ɛA is the molar extinction coefficient of the complex.
RESULTS AND DISCUSSION
By spectral observation analysis, both of the stud-
ied drugs showed absorption in the UV-VIS range. The 
molecular species of ketotifen fumarate and theophylline, 
when observed separately, showed some changes in the 
absorption characteristics of the drug molecules, including 
shifts in the absorption maxima. The initial detection of 
the complexation of ketotifen fumarate with theophylline 
was obtained from the spectra of the pure compounds as 
well as their 1:1, 1:2, and 2:1 mixtures in buffer solutions 
at pH 1.2 and 6.8 at a fixed concentration (1x10-5 M). It is 
clear that each compound has a unique molecular structure 
or electronic configuration which is responsible for the 
absorption of light in the ultraviolet or visible range. For 
this reason, the UV-spectrum of any pure compound will 
be unique and totally different from another compound 
or a complex of that compound with another compound. 
The spectrum of ketotifen fumarate alone at different pH 
showed a sharp absorption maximum at 300 nm. When 
theophylline was mixed with ketotifen in a 2:1 ratio, the 
intensity of the peak of ketotifen changed remarkably 
(decreased absorbance), i.e. the absorption characteristics 
were altered due to the interaction, but the position of the 
compound did not shift. The UV spectra of ketotifen at pH 
1.2 and 6.8 and the 1:1, 1:2, and 2:1 mixtures of ketotifen 
fumarate with theophylline at the same pH are shown 
in Figure 4 and Figure 5. The curves obtained by Job’s 
method show breaks at different molar concentrations for 
both drugs. It was found that the curves obtained at pH 6.8 
were somewhat flat compared to those at pH 1.2. On the 
other hand, the kinetics of the interaction between keto-
tifen fumarate and theophylline anhydrous were slow at 
pH 1.2 (Figure 1). The continuous variation plot provides 
information on the relative affinities of the complexes 
and depends on the intrinsic spectral characteristics of 
each complex. 
Ardon’s plots have been used to evaluate stabil-
ity constants. It has been observed that when values of 
1/(D-CɛA) are plotted against 1/drug (Figure 2), straight 
lines are obtained following Ardon’s equation. The values 
of the stability constants at different pH levels are shown in 
TABLE I - Absorbance of ketotifen at different pH (using Job’s 
method)
Conc. of Ketotifen 
(M)
Absorbance (D Value)
pH 1.2 pH 6.8
1x10-5 0.256 0.288
2x10-5 0.426 0.391
3x10-5 0.564 0.454
4x10-5 0.831 0.506
5x10-5 0.78 0.514
6x10-5 0.67 0.516
7x10-5 0.562 0.445
8x10-5 0.402 0.512
9x10-5 0.237 0.448
FIGURE 1 - Job’s plot for the complexation of ketotifen with 
theophylline at 300 nm.
Table III and Table V. Very low stability constant numeri-
cal values (between negative values and 1) mean that the 
formation of the complex due to an interaction between 
the drugs is readily dissociated (Table V), yielding essen-
tially all drugs in ionic form at low pH as in the stomach 
(about pH 2 to 3) to as high as physiological (pH 7.4, the 
pH of extracellular body fluids such as serum and lymph) 
(Landy et al., 1999).
The numerical values of the resulting stability 
constants were 9.92 at pH 1.2 and 5.66 at pH 6.8 when 
complexation occurred with ketotifen and theophylline 
(Table III). These values indicate a good interaction be-
tween ketotifen and theophylline. It can be assumed that 
these two drugs can be safely administered orally at the 
same time. Following Ardon’s method, when theophyl-
line is considered as the parent drug and interacts with 
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FIGURE 3 - Ardon’s plot for the complexation of theophylline 
with ketotifen at 300 nm.
TABLE II - Absorbance of ketotifen at different pH (using 
Ardon’s method, when the concentration of theophylline is 
constant)
1/D x 10-5
1/ ( D-CeA)
pH 1.2 pH 6.8
1.000 38.5 33.3
0.500 32.3 4.0
0.330 8.4 4.7
0.250 4.5 2.3
0.200 2.9 1.8
0.167 2.0 1.7
0.143 1.5 1.4
TABLE III - Stability constant of ketotifen with theophylline at 
different pH
System pH Stability constant
Interaction of ketotifen with 
theophylline
1.2 9.92
6.8 5.66
TABLE IV - Absorbance of ketotifen at different pH (using 
Ardon’s method, when the concentration of ketotifen is constant)
1/D x 10-5
1/ ( D-CeA)
pH 1.2 pH 6.8
1 3.226 2.577
0.500 3.125 1.724
0.333 3.300 1.754
0.250 3.367 1.698
0.200 3.497 1.761
0.167 3.546 1.715
0.143 3.145 1.698
TABLE V - Stability constant of theophylline with ketotifen at 
different pH
System pH
Stability 
constant 
(1x10-2)
Interaction of theophylline 
with ketotifen
1.2 6.70
6.8 66
FIGURE 2 - Ardon’s plot for the complexation of ketotifen with 
theophylline at 300 nm.
ketotifen, a lower stability constant was found, indicating 
the ready solubility of both drugs and a minimal drug-drug 
interaction (Figure 3).
CONCLUSION
The interaction of ketotifen with theophylline de-
creases the free drug concentration of both drugs, which 
can result in decreased availability of the drugs at their 
receptors. Ultimately, one or both drugs may show dimin-
ished pharmacological activity. Therefore, caution should 
be exercised during the administration of both drugs, 
pending in vivo experiments to determine the implications 
of our findings.
In vitro study on the interaction of ketotifen fumarate with anhydrous theophylline 215
FIGURE 4 - Spectral studies of ketotifen fumarate and 
theophylline at pH 1.2. X axis: UV range; Y axis: absorbance.
FIGURE 5 - Spectral studies of ketotifen fumarate and 
theophylline at pH 6.8 X axis: UV range; Y axis: absorbance.
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